A Study of Herceptin (Trastuzumab) Combination Therapy in Patients With Metastatic Urothelial Cancer

NCT02006667 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Urinary Tract Cancer

Interventions

DRUG: trastuzumab
DRUG: gemcitabine
DRUG: cisplatin

Sponsor

Hoffmann-La Roche